Notify me when L.P. Frazier Life Sciences IX files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MIRM | MIRUM PHARMACEUTICALS, INC. | Common Stock, par value $0.0001 per share | 6.8% | $324,522,832 | +$29,477,804 | 4,108,404 | +10% | Patrick J. Heron | 23 Jan 2026 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|